Literature DB >> 3707783

Factors determining symptoms in heart failure: comparison of fast and slow exercise tests.

D P Lipkin, R Canepa-Anson, M R Stephens, P A Poole-Wilson.   

Abstract

Factors determining the symptoms of breathlessness and fatigue in patients with congestive heart failure were investigated by comparing the response to slow and fast exercise. Symptom limited oxygen consumption (maximal); minute ventilation, mean pulmonary capillary wedge pressure; and arterial blood gases, pH, and lactate concentrations were measured during treadmill exercise using a slow protocol in 25 men (age 34-67 years) with congestive heart failure (New York Heart Association class II-III). Ten of these patients were also exercised according to a rapid protocol. Exercise was terminated by fatigue in 23/25 patients after the slow test and by breathlessness in all patients after the rapid test. Exercise capacity (maximal oxygen consumption and exercise duration) was not related to resting or exercise pulmonary capillary wedge pressure or the change in pulmonary capillary wedge pressure during exercise, nor was there any difference in pulmonary capillary wedge pressure at the end of exercise within individuals between the fast and slow tests. Minute ventilation was greater (51 vs 43 1/min), peak exercise lactate concentration higher (3.7 vs 2.2 mmol/l), and the change in pH from the resting state was greater (0.06 vs 0.02) during the rapid test than during the slow test. The sensation of breathlessness in congestive heart failure is not simply related to raised pulmonary capillary wedge pressure, but may in part be due to stimulation of peripheral chemoreceptors in response to metabolic acidosis.

Entities:  

Mesh:

Year:  1986        PMID: 3707783      PMCID: PMC1216378          DOI: 10.1136/hrt.55.5.439

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  27 in total

1.  The role of anaerobic metabolism in the performance of mild muscular work. I. Relationship to oxygen consumption and cardiac output, and the effect of congestive heart failure.

Authors:  W E HUCKABEE; W E JUDSON
Journal:  J Clin Invest       Date:  1958-11       Impact factor: 14.808

2.  Ventilatory studies in mitral stenosis; a comparison with findings in primary pulmonary disease.

Authors:  N R FRANK; D W CUGELL; E A GAENSLER; L B ELLIS
Journal:  Am J Med       Date:  1953-07       Impact factor: 4.965

3.  Muscular fatigue investigated by phosphorus nuclear magnetic resonance.

Authors:  M J Dawson; D G Gadian; D R Wilkie
Journal:  Nature       Date:  1978-08-31       Impact factor: 49.962

Review 4.  Onset of blood lactage accumulation during muscular exercise as a threshold concept. I. Theoretical considerations.

Authors:  J Karlsson; I Jacobs
Journal:  Int J Sports Med       Date:  1982-11       Impact factor: 3.118

5.  Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization.

Authors:  J A Franciosa; S Ziesche; M Wilen
Journal:  Am J Med       Date:  1979-09       Impact factor: 4.965

6.  Respiratory gas exchange in the assessment of patients with impaired ventricular function.

Authors:  D P Lipkin; J Perrins; P A Poole-Wilson
Journal:  Br Heart J       Date:  1985-09

7.  Exercise hyperventilation in patients with McArdle's disease.

Authors:  J M Hagberg; E F Coyle; J E Carroll; J M Miller; W H Martin; M H Brooke
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-04

8.  Optimizing the exercise protocol for cardiopulmonary assessment.

Authors:  M J Buchfuhrer; J E Hansen; T E Robinson; D Y Sue; K Wasserman; B J Whipp
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-11

9.  Lactate production during maximal and submaximal exercise in patients with chronic heart failure.

Authors:  K T Weber; J S Janicki
Journal:  J Am Coll Cardiol       Date:  1985-10       Impact factor: 24.094

10.  Role of neural afferents from working limbs in exercise hyperpnea.

Authors:  M L Weissman; B J Whipp; D J Huntsman; K Wasserman
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1980-08
View more
  17 in total

Review 1.  Acute cardiovascular response to exercise and its implications for exercise testing.

Authors:  Sachin M Navare; Paul D Thompson
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

Review 2.  Stress testing. Directions for the future.

Authors:  C Foster
Journal:  Sports Med       Date:  1988-07       Impact factor: 11.136

3.  Peripheral and central mechanisms of fatigue in inflammatory and noninflammatory rheumatic diseases.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

4.  Assessing cardiac pumping capability by exercise testing and inotropic stimulation.

Authors:  L B Tan; R J Bain; W A Littler
Journal:  Br Heart J       Date:  1989-07

Review 5.  The role of exercise testing in chronic heart failure.

Authors:  D P Lipkin
Journal:  Br Heart J       Date:  1987-12

Review 6.  Role of exercise ventilation in the limitation of functional capacity in patients with congestive heart failure.

Authors:  M Metra; L Dei Cas
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

Review 7.  Symptoms and quality of life in heart failure: the muscle hypothesis.

Authors:  A J Coats; A L Clark; M Piepoli; M Volterrani; P A Poole-Wilson
Journal:  Br Heart J       Date:  1994-08

Review 8.  Central haemodynamic expressions of heart failure.

Authors:  F Burkart
Journal:  Br Heart J       Date:  1994-08

9.  Effects of lisinopril on cardiorespiratory, neuroendocrine, and renal function in patients with asymptomatic left ventricular dysfunction.

Authors:  J G Cleland; D Shah; S Krikler; A Dritsas; P Nihoyannopoulos; G Frost; C M Oakley
Journal:  Br Heart J       Date:  1993-06

10.  The influence of exercise tolerance on quality of life among patients with heart failure.

Authors:  Chii Jeng; Mei-Hsing Yang; Pao-Lo Chen; Chiung-Hua Ho
Journal:  Qual Life Res       Date:  2004-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.